Leadership Bios

M. Juliana McElrath, MD, PhD
Director of Laboratories

Dr. Julie McElrath directs the HVTN Laboratory Program. She is a professor of medicine at the University of Washington; member of the Clinical Research Division, Fred Hutchinson Cancer Research Center; principal investigator of the FHCRC/UW HIV Vaccine Trials Unit; and associate head of the Program in Infectious Diseases, Fred Hutchinson Cancer Research Center. Dr. McElrath also has attending responsibilities on the Fred Hutchinson Cancer Research Center Infectious Diseases consult service.

Dr. McElrath has held a number of national leadership responsibilities, including recent chairmanship of the HIV immunology study section (ARR2), co-chair of the NIH PAVE Laboratory Working Group, member of the HIV Vaccine Enterprise Laboratory Working Group and associate editor of the Journal of Infectious Diseases. She is a member of the Association of American Physicians and a received a Burroughs-Wellcome Clinical Scientist Translational Award and an NIH Merit Award. She has extensive experience with leading and participating in large multidisciplinary studies and international collaborations. Ongoing investigations include understanding mechanisms of controlling HIV in exposed seronegatives, acutely infected patients and long-term non-progressors. Her laboratory focuses on insights into mucosal immunology as a means to slow HIV transmission.

Dr. McElrath received her bachelor’s degree from Furman University, Greenville, SC; PhD and MD from the Medical University of South Carolina, Charleston; infectious diseases clinical training at Columbia Presbyterian Medical Center, New York; and post-doctoral training at the Rockefeller University in New York.


Explore further:	Leadership Bios M. Juliana McElrath, MD, PhD Director of Laboratories Dr. Julie McElrath directs the HVTN Laboratory Program. She is a professor of medicine at the University of Washington; member of the Clinical Research Division, Fred Hutchinson Cancer Research Center; principal investigator of the FHCRC/UW HIV Vaccine Trials Unit; and associate head of the Program in Infectious Diseases, Fred Hutchinson Cancer Research Center. Dr. McElrath also has attending responsibilities on the Fred Hutchinson Cancer Research Center Infectious Diseases consult service. Dr. McElrath has held a number of national leadership responsibilities, including recent chairmanship of the HIV immunology study section (ARR2), co-chair of the NIH PAVE Laboratory Working Group, member of the HIV Vaccine Enterprise Laboratory Working Group and associate editor of the Journal of Infectious Diseases. She is a member of the Association of American Physicians and a received a Burroughs-Wellcome Clinical Scientist Translational Award and an NIH Merit Award. She has extensive experience with leading and participating in large multidisciplinary studies and international collaborations. Ongoing investigations include understanding mechanisms of controlling HIV in exposed seronegatives, acutely infected patients and long-term non-progressors. Her laboratory focuses on insights into mucosal immunology as a means to slow HIV transmission. Dr. McElrath received her bachelor’s degree from Furman University, Greenville, SC; PhD and MD from the Medical University of South Carolina, Charleston; infectious diseases clinical training at Columbia Presbyterian Medical Center, New York; and post-doctoral training at the Rockefeller University in New York.